ROR1
ROR1是受體酪氨酸激酶樣孤兒受體(ROR)家族成員之一,屬于I型受體酪氨酸激酶 (receptor tyrosine kinase, RTK)家族。與核受體中的ROR家族不同,ROR是一類(lèi)膜受體。ROR1可通過(guò)介導(dǎo)非經(jīng)典Wnt信號(hào)通路(non-canonical Wnt pathways)的信號(hào)傳遞,在多種生理過(guò)程中發(fā)揮重要作用,其中包括調(diào)節(jié)細(xì)胞分裂、增殖、遷移、和細(xì)胞趨化,尤其是Wnt5a。現(xiàn)有研究表明,Wnt5a/ROR1在多種癌癥中的高度表達(dá)。作為Wnt5a的受體,ROR1參與激活腫瘤細(xì)胞NF-κB通路。NF-κB通路是炎癥反應(yīng)和免疫調(diào)控的掌舵者,在多種腫瘤類(lèi)型中組成性激活。此外,ROR1的表達(dá)與YAP/TAZ轉(zhuǎn)錄的激活相關(guān)聯(lián),從而增強(qiáng)腫瘤發(fā)生和化學(xué)耐藥性。ROR1被認(rèn)為是個(gè)非常有潛力的靶點(diǎn),因?yàn)樗鳛槔野彼峒っ甘荏w,具有可藥性;其次,它在細(xì)胞表面表達(dá);更重要的是,它在腫瘤細(xì)胞中高度表達(dá),而在成人健康組織中表達(dá)量很低。目前有多家公司在開(kāi)發(fā)靶向 ROR1 的抗癌療法,其中包括單克隆抗體、抗體偶聯(lián)藥物(ADC)、雙特異性抗體、以及 CAR-T療法等多種治療模式。
Recombinant Human ROR1 活性蛋白實(shí)驗(yàn)驗(yàn)證數(shù)據(jù)
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Measured by its binding ability in a functional ELISA. Immobilized ROR1 at 2 μg/ml can bind anti-ROR1 antibody(CSB-RA020067A1HU), the EC50 is 0.2450-0.3416 ng/mL.
ROR1 Antibodies
ROR1 for Homo sapiens (Human)
產(chǎn)品貨號(hào) | 產(chǎn)品名稱(chēng) | 種屬反應(yīng)性 | 應(yīng)用類(lèi)型 |
---|---|---|---|
CSB-PA020067LC01HU | ROR1 Antibody, FITC conjugated | Human | |
CSB-PA020067GA01HU | ROR1 Antibody | Human,Mouse,Rat | ELISA,WB |
CSB-PA067964 | ROR1 Antibody | Human,Mouse | ELISA,IHC |
CSB-PA993257 | ROR1 Antibody | Human,Mouse | ELISA,IHC |
CSB-PA020067LA01HU | ROR1 Antibody | Human | ELISA, IHC |
ROR1 Proteins
ROR1 Proteins for Homo sapiens (Human)
產(chǎn)品貨號(hào) | 產(chǎn)品名稱(chēng) | 來(lái)源 |
---|---|---|
CSB-YP020067HU | Recombinant Human Tyrosine-protein kinase transmembrane receptor ROR1 (ROR1), partial | Yeast |
CSB-EP020067HU | Recombinant Human Tyrosine-protein kinase transmembrane receptor ROR1 (ROR1), partial | E.coli |
CSB-MP020067HU1d7 | Recombinant Human Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1), partial (Active) | Mammalian cell |